Press release
Autoinjectors Market worth $1.7 billion | Revealing Emerging Players with New Data Insights
2023 Autoinjectors Market
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral
Rheumatoid Arthritis subsegment accounted for the largest share of the autoinjectors market by therapy area
Among the therapy area, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, and other therapy areas. In 2023, the rheumatoid arthritis segment accounted for the largest share of the autoinjectors market by therapy area.
Key Market Players
The market for autoinjectors is consolidated, with key players strategizing to capture majority of the market. Prominent players in the market are Becton, Dickinson and Company (BD) (US), Ypsomed Holding AG (Switzerland), SHL Medical (Switzerland), West Pharmaceutical Services, Inc. (US), Recipharm AB (Sweden), Haselmeier GmbH (Germany), Owen Mumford Ltd. (UK), Gerreshiemer AG (Germany), Philip-Medisize, LLC (US), Oval Medical Technologies Ltd. (UK), Solteam Incorporation Co., Ltd. (China), Elcam Drug Delivery Devices (E3D) (Israel), Antares Pharma, Inc. (US), Jabil, Inc. (US), and the some of the major market players for finished formulations covered in this chapter include AbbVie Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), Novartis AG (Switzerland), Merck KGaA (Germany), Viatris Inc. (US), and Biogen (US).
Becton, Dickinson and Company (BD)
BD is the leading players in the global autoinjector devices market. The company offers self-injection device systems. BD is focused on strategies such as innovation, expansions, and partnerships to enhance its presence in the autoinjectors market. For instance, the company has successfully conducted human clinical trials for the BD Libertas wearable injector.
Ypsomed Holding AG
Ypsomed Holding AG is one of the leading players in the global autoinjector devices market. Ypsomed offers self-injection device systems along with infusion systems. The has a strong geographic presence along with patient-centric autoinjector products are contributing to its growing market share.
AbbVie Inc.
AbbVie is one of the leading players in the Autoinjectors finished formulations market. The company's blockbuster product is Humira Pen. AbbVie has a strong supply chain globally with wholesalers, distributors, government agencies, healthcare facilities, specialty pharmacies, and independent retailers marketing its products worldwide.
Amgen Inc.
Amgen focuses on discovery, development, manufacturing, and marketing of innovative human therapeutics. The company is engaged in the production of innovative medicines, expanding its global geographic reach, enhancing next-generation biomanufacturing, improving drug delivery systems, and offering branded biosimilars.
Browse Complete Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html?utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral
Europe: The second-largest region in the autoinjectors market.
The European autoinjectors market is the second-largest autoinjectors market globally, mainly due to factors such as presence of a large geriatric population in the region and the improving reimbursement and regulatory scenario. The presence of large geriatric population in the region is expected to increase the prevalence of chronic diseases leading consequently leading to growing adoption of autoinjectors for treatment of these disease.
Recent Developments:
• In May 2023, SHL Medical and MoonLake Immunotherapeutics collaborated to develop the sonelokimab autoinjector. SHL Medical's Molly autoinjector technology will be utilized for the clinical and potential commercial supply of MoonLake's Nanobody sonelokimab.
• In October 2022, BD partnered with Biocorp for Biocorp's Injay technology, which adds connectivity to prefilled syringes. It is expected to aid BD in tracking adherence to self-administered injectable drugs.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173991724&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoinjectors Market worth $1.7 billion | Revealing Emerging Players with New Data Insights here
News-ID: 3113467 • Views: …
More Releases from marketsandmarket
With 13.6%CAGR, Zinc Battery Market Growth to Surpass USD 2.0 billion
According to MarketsandMarkets, the Zinc Battery Market is estimated to be USD 1.0 billion in 2024 and projected to reach USD 2.0 billion by 2029, at a CAGR of 13.6% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171978019
Zinc batteries are anticipated to play a critical role in the future energy landscape, driven by the global shift from fossil fuels to renewable energy sources. This transition necessitates substantial electricity storage…
Strategic Innovations in Industrial Valves Industry Leading to $99.8 Billion Mar …
The global industrial valves market size is expected to grow from USD 80.4 billion in 2023 to USD 99.8 billion by 2028, at a CAGR of 4.4%. The growth of the industrial valves market can be attributed to the growing demand for industrial valves from healthcare and pharmaceutical industries, establishment of new power plants and revamping of existing ones, rising demand for adoption of automation solutions, and establishment of smart…
Vaccines Market worth $93.8 billion by 2028
Vaccines Market in terms of revenue was estimated to be worth $77.6 billion in 2023 and is poised to reach $93.8 billion by 2028, growing at a CAGR of 3.9% from 2023 to 2028 according to a new report by MarketsandMarkets.
The global vaccines market is expected to grow at a CAGR of 3.9% during the forecast period. The growth of the market is projected to be driven by factors such…
Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong…
More Releases for Autoinjectors
Elevated Prevalence Of Chronic Diseases Sparks Growth In The Autoinjectors Marke …
The Autoinjectors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Autoinjectors Market?
In recent times, the autoinjectors market has experienced substantial growth. Projections indicate that it will expand from a valuation of $3.7 billion in 2024 to $4.55 billion…
Automated Autoinjectors Market
The "Automated Autoinjectors Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Automated Autoinjectors Market, 2024-2031
Verified Market Research's most recent report, "Automated Autoinjectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination…
Autoinjectors Market worth $ 226.37 Million by 2030
Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Autoinjectors Market- by Type (Disposable Autoinjectors and Reusable Autoinjectors) Applications (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis and Others), End-User (Home care settings and Hospitals & Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1234
According to the latest research by Insightace Analytics, the global autoinjectors market was valued at US$ 47.13 Million…
Reusable Autoinjectors Market Size - Forecast to 2026
As per the research conducted by GME, the Global Reusable Autoinjectors Market is projected to grow at a CAGR value of 11.7% during the forecast period [2021 to 2026].
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Reusable Autoinjectors Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/reusable-autoinjectors-market-3325
By Dose (Fixed and Variable), By Technology (Smart Autoinjectors, Conventional Autoinjectors) By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple…
Autoinjectors Market 2022 Trends and Review
ReportsWeb.com has announced the addition of the “Global Autoinjectors Market Research Report 2017” The report focuses on global major leading players with information such as company profiles, product picture and specification.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Autoinjectors in these regions, from 2012 to 2022 (forecast) , covering North America, Europe, China, Japan, Southeast Asia…
Autoinjectors Market 2016: Disposable Autoinjectors, Reusable Autoinjectors
Autoinjector is a medical device used to dispense a single dose of a drug, particularly, life-saving drugs. These Autoinjectors are usually spring-loaded syringes that are particularly designed for easy and safe administration of the drugs. The injectable drug delivery method is a technology driven market and has experienced a paradigm shift. The traditionally used self-injection devices, which were merely used for delivering human growth hormones and insulin are currently replaced…
